Central technology in ASTONISH (smart optical imaging for health) and PHOOTONICS (hyperspectral device for diabetic foot).
QUEST MEDICAL IMAGING BV
Dutch SME building hyperspectral and NIR/mid-IR imaging devices for medical use, with a recent focus on diabetic foot monitoring.
Their core work
Quest Medical Imaging is a Dutch SME that develops advanced optical and hyperspectral imaging systems for medical applications. Their core work sits at the intersection of photonics hardware (image sensors, photodetectors, NIR and mid-IR illumination) and clinical imaging software, turning light-based measurements into diagnostic tools. Recent projects focus on translating hyperspectral imaging into practical bedside devices — for example, a photonics-based device to predict and monitor diabetic foot complications. They serve as a technology partner that bridges sensor engineering and real clinical use cases.
What they specialise in
Explicit focus in PHOOTONICS on passive photodetectors and active illuminators across NIR and mid-IR bands, building on image sensor work in EXIST.
PHOOTONICS targets early prediction and management of diabetic foot, a specific chronic-care clinical workflow.
EXIST (Extended Image Sensing Technologies) addressed sensor-level innovation within the ECSEL programme.
All three projects (EXIST, ASTONISH, PHOOTONICS) follow a path from generic imaging tech toward validated medical products.
How they've shifted over time
In 2015–2018 their involvement (EXIST, ASTONISH) centred on the underlying hardware layer: image sensing technologies and smart optical imaging platforms for health, with no specific disease focus visible in the keywords. From 2019 onward (PHOOTONICS, running to 2024) the work narrowed sharply onto a concrete clinical problem — diabetic foot — combining hyperspectral imaging with NIR and mid-IR photodetectors. The trajectory is classic SME maturation: generic photonic building blocks in the early years, a targeted clinical product in the recent years.
They are moving from horizontal photonics R&D toward commercialisable clinical imaging products, so they are a fit for consortia that need a partner ready to turn imaging research into a CE-marked medical device.
How they like to work
Quest Medical Imaging consistently joins projects as a third party rather than coordinating, contributing specialist imaging know-how inside larger photonics and ECSEL consortia. Across three projects they have worked with 49 distinct partners in 12 countries, suggesting a broad, non-loyal network typical of a technology SME that plugs into whichever consortium needs their imaging stack. For collaborators this means they are accessible as a focused technical contributor, not as a project-management lead.
They have collaborated with 49 unique partners across 12 countries, anchored in Dutch and wider Northwest European photonics and ECSEL networks. The network is broad rather than repeat-partner focused, indicating exposure to many different research groups and industrial players.
What sets them apart
Few small European companies combine deep image-sensor and photodetector engineering with direct involvement in clinical imaging applications — Quest Medical Imaging does both. Their progression from ECSEL-level sensor work to a diabetic-foot device gives them an unusual "hardware-up to clinic" view of the value chain. Partners looking for a Dutch SME that can take hyperspectral components and shape them into a device used in a hospital setting will find a rare fit here.
Highlights from their portfolio
- PHOOTONICSTheir most recent and most focused project, turning hyperspectral NIR/mid-IR imaging into a cost-effective device for diabetic foot management — the clearest signal of their current commercial direction.
- ASTONISHPositioned them inside a pan-European smart optical imaging consortium for health, bridging their sensor background with clinical imaging use cases.
- EXISTECSEL-funded work on extended image sensing technologies — the hardware foundation their later medical imaging work builds on.